Status
Conditions
Treatments
About
The study evaluate the damage effect of ESWL and PCNL on kidney tissue by measuring non-coding lnc-RNA profile in urine before and after ESWL and PCNL procedures
Full description
The study evaluate the damage effect of ESWL and PCNL on kidney tissue by measuring non-coding lnc-RNA profile in urine before and after ESWL and PCNL procedures and assess their usefulness as diagnostic biomarkers for AKI and the relationship between the selected RNA based biomarker panel and clinicopathological changes of patients.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Inclusion criteria for patients :
Inclusion criteria for Healthy volunteers
Exclusion criteria
Exclusion criteria for patients
Primary purpose
Allocation
Interventional model
Masking
75 participants in 3 patient groups
Loading...
Central trial contact
Ahmed Tawfick, MD; waleed Mousa, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal